Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.

MLA

Madhivanan, P., et al. “Longitudinal Assessment of Nonavalent Vaccine HPV Types in a Sample of Sexually Active African American Women from Ten U.S. Cities.” Vaccine, vol. 39, no. 34, Aug. 2021, pp. 4810–16. EBSCOhost, https://doi.org/10.1016/j.vaccine.2021.07.026.

APA

Madhivanan, P., Krupp, K., Coudray, M., Colbert, B., Ruiz-Perez, D., Cui, H., Bokulich, N., Narasimhan, G., Mathee, K., Cook, R. L., Schwebke, J., & Roe, D. (2021). Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities. Vaccine, 39(34), 4810–4816. https://doi.org/10.1016/j.vaccine.2021.07.026

Chicago

Madhivanan, P, K Krupp, M Coudray, B Colbert, D Ruiz-Perez, H Cui, N Bokulich, et al. 2021. “Longitudinal Assessment of Nonavalent Vaccine HPV Types in a Sample of Sexually Active African American Women from Ten U.S. Cities.” Vaccine 39 (34): 4810–16. doi:10.1016/j.vaccine.2021.07.026.